A
Allan Blemings
Publications - 5
Citations - 731
Allan Blemings is an academic researcher. The author has contributed to research in topics: Varicose veins & Sclerotherapy. The author has an hindex of 5, co-authored 5 publications receiving 622 citations.
Papers
More filters
Journal ArticleDOI
Randomized trial comparing endovenous laser ablation of the great saphenous vein with high ligation and stripping in patients with varicose veins: Short-term results
TL;DR: This study suggests that the short-term efficacy and safety of EVL and HL/S are similar, and the treatments were equally safe and efficient in eliminating GSV reflux, alleviating symptoms and signs of GSV varicosities, and improving quality of life.
Journal ArticleDOI
Randomized clinical trial comparing endovenous laser ablation and stripping of the great saphenous vein with clinical and duplex outcome after 5 years.
TL;DR: Five-year follow-up of the first randomized controlled trial comparing endovenous laser ablation with high ligation and pin-stripping in patients with great saphenous vein incompetence showed no significant difference between the two groups in primary or secondary end points, perhaps because of the small sample size.
Journal ArticleDOI
Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy, and surgical stripping for great saphenous varicose veins with 3-year follow-up.
Lars Melholt Rasmussen,Martin Lawaetz,Julie Serup,Lars Bjoern,Bo Vennits,Allan Blemings,Bo Eklof +6 more
TL;DR: All treatment modalities were efficacious and resulted in a similar improvement in VCSS and QOL, however, more recanalization and reoperations were seen after UGFS, and the patterns of reflux and location of recurrent varicose veins were not different between the groups.
Journal ArticleDOI
Comparison of endovenous ablation techniques, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Extended 5-year follow-up of a RCT.
Martin Lawaetz,Julie Serup,Birgit Lawaetz,Lars Bjoern,Allan Blemings,Bo Eklof,Lars Melholt Rasmussen +6 more
TL;DR: The higher frequency of clinical recurrence after EVLA and HL/S cannot be explained and requires confirmation in other studies.